Engineered CRISPR-Cas13a system with enhanced target RNA cleavage activity and reduced collateral activity for therapeutic applications. [PDF]
Zhang W +9 more
europepmc +1 more source
Toward Wireless Implantable Robotic Systems Driven by Magnetic Field for Personalized Therapy
Robotic materials are playing an increasingly vital role in enabling sensing and actuation at small scales. This perspective highlights recent advances in magnetic materials and magnetically actuated devices for wireless sensing, actuation, and energy harvesting toward implantable robotic systems for closed‐loop therapy.
Yusheng Wang, Ruijian Ge, Xiaoguang Dong
wiley +1 more source
Nanoparticle-based drug delivery systems: A promising approach for the treatment of liver fibrosis. [PDF]
Chen YN +10 more
europepmc +1 more source
Magnetic Field Driven Microrobot Based on Hydrogels
Hydrogel‐based magnetic microrobots synergize remote magnetic control with the biocompatibility of flexible hydrogels, emerging as promising tools for minimally invasive biomedicine. This enables remotely controllable, untethered navigation within complex biological microenvironments.
Juncai Song, Yubing Guo
wiley +1 more source
An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment. [PDF]
Maeda K +11 more
europepmc +1 more source
A Superlubricated Magnetically Steerable Microcatheter with Integrated Optical and Fluidic Channels
A magnetically steerable microcatheter with integrated optical and fluidic channels is developed for multifunctional navigation in tortuous anatomical environments. A surface‐grafted hydrogel coating enables low‐friction actuation. The device demonstrates stable light and fluid delivery during magnetic manipulation, offering a compact platform for ...
Yuntian Du +5 more
wiley +1 more source
Site-blocking antisense oligonucleotides as a mechanism to fine-tune MeCP2 expression. [PDF]
Vanderplow AM +6 more
europepmc +1 more source
Rheumatoid arthritis is a disease characterized by joint inflammation. Approximately 50% of patients show insufficient response to traditional synthetic disease‐modifying antirheumatic drugs. This study aims to elucidate differential molecular profiles of the mechanisms underlying drug responses through multi‐omics strategy.
Congcong Jian +26 more
wiley +1 more source
Tailored antisense oligonucleotides for ultrarare CNS diseases: An experience-based best practice framework for individual patient evaluation. [PDF]
Schüle R +6 more
europepmc +1 more source
This study identifies TRIM47 as a key driver of liver cancer progression by promoting glycolysis through ubiquitin‐mediated degradation of the gluconeogenic enzyme FBP1. TRIM47 enhances glucose uptake, lactate and ATP production, and tumor growth and metastasis.
Weijie Sun +17 more
wiley +1 more source

